期刊文献+

心电图QRS波时限对慢性左心衰竭患者短期预后的影响 被引量:9

The influences of QRS complex duration in patients with chronic left heart failure
下载PDF
导出
摘要 目的探讨QRS波时限对慢性左心衰竭患者短期预后的影响。方法选取2014年1月至2015年6月北京大学第一医院纽约心功能分级(NYHA)Ⅲ~Ⅳ级的慢性左心衰竭住院患者174例,据QRS波时限分为QRS波时限正常组(145例,QRS波时限≤120 ms)、QRS波时限延长组(29例,QRS波时限〉120 ms),比较两组患者一般临床特征及住院期间左心衰竭急性加重、致命性心律失常和心原性死亡发生情况的差异。采用logistic回归模型分析慢性左心衰竭患者住院期间发生不良心血管事件的影响因素。结果 QRS波时限延长组的男性占比(75.9%比43.4%,P=0.001)、B型脑钠肽的自然对数(ln BNP)(7.1±0.8比6.6±1.0,P=0.020)、左心室舒张末期内径(LVEDd)[(60.7±9.9)mm比(53.5±10.8)mm,P=0.001]及左心室收缩末期内径(LVESd)[(49.1±13.3)mm比(39.7±13.0)mm,P〈0.001],住院期间左心衰竭急性加重(20.7%比4.8%,P=0.003)、致命性心律失常(55.2%比21.4%,P〈0.001)和心原性死亡(6.9%比0.7%,P=0.019)发生率均较QRS波时限正常组高;左心室射血分数(LVEF)较QRS波时限正常组低[(39.6±17.3)%比(50.5±17.3)%,P=0.002]。按性别分层后,男性QRS波时限延长组的心率[(92.4±21.4)次/min比(81.6±19.9)次/min,P=0.035]、ln BNP(7.2±0.8比6.7±1.0,P=0.029)、LVEDd[(63.5±9.1)mm比(57.9±9.1)mm,P=0.015]、LVESd[(52.9±12.2)mm比(44.3±11.8)mm,P=0.005],住院期间左心衰竭急性加重(18.2%比3.2%,P=0.018)、致命性心律失常(63.6%比36.5%,P=0.027)和心原性死亡(9.1%比0,P=0.015)发生率均较QRS波时限正常组高;LVEF较QRS波时限正常组低[(35.0±15.3)%比(47.1±16.2)%,P=0.003]。女性QRS波时限延长组住院期间的左心衰竭急性加重发生率较QRS波时限正常组高(28.6%比6.1%,P=0.034)。相关性分析显示,QRS波时限与LVEDd(r=0.4019,P〈0.001)和LVESd(r=0.3289,P〈0.001)均呈正相关。男性组LVEF较� Objective To study the effects of QRS-complex duration of patients with chronic left heart failure on their in-hospital prognosis. Methods Total 174 patients admitted for chronic left heart failure( New York Heart Association class 3 and 4) from January 2014 to June 2015 were enrolled the study. They were divided into two groups according to the QRS duration at admission: normal QRS duration group( QRS ≤120 ms,n = 145) and prolonged QRS group( QRS 120 ms,n = 29). The differences of clinical characteristics and incidences of exacerbated left heart failure,fatal arrhythmias and cardiac death during hospitalization were compared between the two groups. The influences of QRS duration on in-hospital adverse cardiovascular events was analyzed by logistic regression. Results The proportion of males( 75. 9% vs. 24. 1%,P = 0. 001),plasma B-type natriuretic peptide( BNP)( 7. 1 ± 0. 8 vs. 6. 6 ± 1. 0,P= 0. 02),left ventricular end diastolic diameter( LVEDd) [( 60. 7 ± 9. 9) mm vs.( 53. 5 ± 10. 8) mm,P =0. 001],left ventricular end systolic diameter( LVESd) [( 49. 1 ± 13. 3) mm vs.( 39. 7 ± 13. 0) mm,P〈 0. 001],and the incidence of exacerbated left heart failure( 20. 7% vs. 4. 8%,P = 0. 003),fatal arrhythmias( 55. 2% vs. 21. 4%,P〈 0. 001) and cardiac death( 6. 9% vs. 0. 7%,P = 0. 019) during hospitalization were significantly higher in the prolonged QRS group than in the normal QRS group. Left ventricular ejection fraction( LVEF) in the prolonged QRS group was significantly lower than in the normal QRS group( 39. 6% ± 17. 3% vs. 50. 5% ± 17. 3%,P = 0. 002). Heart rates [( 92. 4 ± 21. 4) bpm vs.( 81. 6 ± 19. 9) bpm,P = 0. 035],plasma BNP( 7. 2 ± 0. 8 vs. 6. 7 ± 1. 0,P = 0. 029),LVEDd( 63. 5 ± 9. 1vs. 57. 9 ± 9. 1,P = 0. 015),LVESd( 52. 9 ± 12. 2 vs. 44. 3 ± 11. 8,P = 0. 005),incidences of left heart failure deterioration( 18. 2% vs. 3. 2%,P = 0. 018),fatal arrhythmias( 63. 6% vs. 36. 5%,P = 0. 027)and cardia
出处 《中国介入心脏病学杂志》 2016年第3期154-159,共6页 Chinese Journal of Interventional Cardiology
关键词 心电图 QRS波时限 慢性左心衰竭 预后 危险因素 Electrocardiography QRS complex duration Chronic left heart failure Prognosis Risk factors
  • 相关文献

参考文献4

二级参考文献79

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209. 被引量:4
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095. 被引量:31
  • 4Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416. 被引量:1
  • 5Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442. 被引量:1
  • 6Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82. 被引量:1
  • 7Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016. 被引量:1
  • 8Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88. 被引量:1
  • 9Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16. 被引量:1
  • 10Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 2006, 27 : 839-845. 被引量:1

共引文献5497

同被引文献65

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部